Page 14 - Cures Act News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Clinicians and consumers are deprived of the full picture needed for informed decision-making

The U.S. Food and Drug Administration is approving more novel pharmaceutical drugs based on single clinical trials and with less public disclosure about those trials than was the norm just

Zak, CEO of Hint Health, is on a mission to transform the healthcare landscape by fostering a direct link between patients and doctors through the Direct Primary Care (DPC) movement. He discusses his role, experience, and the intersection of healthcare, technology, and venture capital.

The U.S. Food and Drug Administration is approving more novel pharmaceutical drugs based on single clinical trials and with less public disclosure about those trials than was the norm just a few years ago, a pair of recent studies from Oregon State University found.

Legislative proposals to protect reproductive health data in Maryland could set a precedent in the United States, says Nichole Sweeney,general counsel and chief privacy officer at CRISP, the state-designated health information exchange of Maryland, and CRISP Shared Services, a nonprofit infrastructure organization supporting six HIEs across the U.S. In a Q&A with Healthcare IT News, Sweeney also explains why electronic health record vendors can better partner with healthcare organizations to maintain interoperability, stay in compliance with information blocking rules under the Cures Act ...